]>
IRCT20200819048463N1 IRCT 2020-11-19 Esfahan University of Medical Sciences The effect of Curcumin on the improvement of patients undergoing nose surgury The effect of Curcumin on the improvement of patients undergoing rhinoplasty 2020-08-22 anticipated 110 Complete https://irct.ir/trial/51042 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: 110 patients who meet the inclusion criteria are admitted to the study as unlikely and easy, and the treatment is assigned to two groups randomly with the help of web-based randomization. To do this, the website www.grphpad.com is used to generate a random sequence for two-group trials. The unit is an individual randomization. First, the names of all 110 patients are prepared as a list and are numbered from one to one hundred and ten, respectively. In the second step, in the new randomization section of the website, enter the number of people in each sample, which is 55, and then press the button. Web site sequencing equates one to one hundred and ten options A or B equally. Individuals assigned to group A are treated with curcumin and those assigned to group B are treated with medication. They will be placed on the facade, Blinding description: Participants, researchers, and outcome evaluators and data analysts do not know which group every person belong toIn such a way that an independent person is selected as a random divider of patients and a distributor of drugs among selected patients, the doctor refers each patient to that person and he / she, based on the random list he / she has prepared, gives each patient the medicine that should be in his / her group. To receive. 3 Evaluation of the effect of curcumin on the recovery of patients after rhinoplasty. Intervention 1: Intervention group: Curcumin reciverFor this group of patients Curcomax capsules should be given, it is considered that this capsule was made by Health Company in England, and each 500 mg capsule contains 400 mg of turmeric extract or root. The patient has been taking one of these oral capsules daily since the day after surgery and has been taking this medicine for a month. Intervention 2: Control group: Placebo receiverFor this group of patients, placebo medicine with the same shape, weight, color and packaging has been prepared by the same company, and each patient uses a 500 mg placebo capsule daily from the first day after surgery and takes this medicine for a long time. Consumes a month. Yes - There is a plan to make this available What will be shared: All data can be published When: 6 months after printing the results To whom: All Conditions: Nothing Where to obtain: Isfahan University of Medical Sciences How to obtain: By referring to the university library, the Taza form is registered and the data is given Comments:
public Doctor Ahmad rezaeian
Shams abady street, Hzaer town
Esfahan Iran (Islamic Republic of) 4565234566 +98 31 3436 9336 Dr.Ahmadrezaeian@gmail.com Esfahan University of Medical Sciences scientific Ahmad Rezaeian
Esfahan Town, shamsabady Ave, Hezare building, No 23
Esfahan Iran (Islamic Republic of) 9876556778 +98 31 3223 4622 Dr.Ahmadrezaeian@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Patients undergoing rhinoplasty due to dissatisfaction with the shape of the nose No history of allergy to Curcumin Satisfaction to participate in this study No sinusitis No nasal polyps No systemic diseases No MS No cleft palate or lips or both Lack of space-absorbing mass in the nose no limit no limit Both Do not use medicine Do not use other anti-inflammatory drugs Treatment - Drugs Treatment - Drugs Intervention group: Curcumin reciverFor this group of patients Curcomax capsules should be given, it is considered that this capsule was made by Health Company in England, and each 500 mg capsule contains 400 mg of turmeric extract or root. The patient has been taking one of these oral capsules daily since the day after surgery and has been taking this medicine for a month. Control group: Placebo receiverFor this group of patients, placebo medicine with the same shape, weight, color and packaging has been prepared by the same company, and each patient uses a 500 mg placebo capsule daily from the first day after surgery and takes this medicine for a long time. Consumes a month Nasal obstruction septoplasty effectiveness(NOSE) score. Timepoint: Before, one week, two weeks and one month after surgery. Method of measurement: NOSE scale. Sino nasal outcome test 22 (SNOT22) score. Timepoint: Before, one week, two weeks and one month after surgery. Method of measurement: SNOT22 scale. Esfahan University of Medical Sciences Approved 2020-02-01 Ethics Committee of Isfahan University of Medical Sciences Hzarjerib street Esfahan Isfehan Iran (Islamic Republic of)